Model for end stage liver disease for prediction of mortality in people with cirrhosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Model for End Stage Liver Disease for Prediction of Mortality in People With Cirrhosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432634/0/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Edited__no_change_to_conclusions_. Accessed 18 April 2024.
Model for end stage liver disease for prediction of mortality in people with cirrhosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/0/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Edited__no_change_to_conclusions_. Accessed April 18, 2024.
Model for end stage liver disease for prediction of mortality in people with cirrhosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/0/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Edited__no_change_to_conclusions_
Model for End Stage Liver Disease for Prediction of Mortality in People With Cirrhosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/0/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Model for end stage liver disease for prediction of mortality in people with cirrhosis
ID - 432634
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/0/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -